Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT06604611
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT06604611
-
- Other papers using this trial's data
- Colchicine in acutely decompensated heart failure: the COLICA trial
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06604611. Randomized; no masking; primary purpose treatment. Start 2024-10-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
- Acronym
- CHIPS
- Condition
- Heart Failure
- Condition
- Heart Failure With Preserved Ejection Fraction (HFPEF)
- Condition
- Chronic Inflammation
- Condition
- Inflammation
- Condition
- Colchicine
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet Once Daily
- Lead sponsor
- Dongying Zhang
- Collaborator
- National Natural Science Foundation of China
Record details
- Record id
cardio:ct-nct06604611- Content hash
2913e426cd4340056df5d98db6cd9b9c7a4874f996d5d8aa6753f9e9f0b81de1